CancerLife, a Digital Health Company, With the Validation Institute, Announces Results of Its Phase 3 Trial That Raised EQ-5 Quality of Life (QOL) Scores by 14.3% PHILADELPHIA, June 02, 2022 (GLOBE NEWSWIRE) -- CancerLife, a digital therapeutics company with the Validation Institute, announced the results of its two-arm, fully randomized Phase 3 clinical...